Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 31St January, 2022

POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2022 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday, the 31st January, 2022, inter alia to consider the following: a) To consider and approve the Un-Audited Financial Results of the Company for the Third quarter and Nine months ended on 31st December, 2021. b) To transact any other matter which the Board may deem fit.
18-01-2022
Bigul

POLY MEDICURE LTD. - 531768 - Closure of Trading Window

It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Saturday, the 1st January, 2022 till the end of 48 hours after the declaration of Financial Results for the quarter and nine months ended on 31st December, 2021. The date of the Board Meeting to consider the above financial results would be intimated to the Stock Exchange in due course. You are hereby requested to please take the above information on your records.
31-12-2021
Bigul

POLY MEDICURE LTD. - 531768 - Disclosure Of Related Party Transactions For The Half Year Ended On 30Th September, 2021

Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed herewith disclosure of Related Party Transactions drawn in accordance with applicable Accounting Standards for the half year ended on 30th September, 2021. Kindly take a note of the same for your further needful and oblige us.
22-11-2021

Earnings Call for Q2FY22 of Muthoot Finance

Conference Call with Poly Medicure Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
08-11-2021
Bigul

Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Monday, 8th November, 2021 at 3.30 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 30th September, 2021. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record.
02-11-2021
Bigul

Poly Medicure Ltd - 531768 - OUTCOME OF BOARD MEETING - UNAUDITED HALF YEARLY FINANCIAL RESULTS.

Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 1st November, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Standalone & Consolidated) for the Second quarter and half year ended on 30th September 2021. b) Allotted 19,775 Equity Shares of Rs. 5 each, pursuant to exercise of an option under Employee Stock Option Scheme, 2016. c) Other Routine Businesses. Kindly take a note of the same for your further needful and oblige us. Thanking You,
01-11-2021
Bigul

Poly Medicure Ltd - 531768 - Board Meeting Outcome for OUTCOME OF BOARD MEETING DATED 01.11.2021

Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 1st November, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Standalone & Consolidated) for the Second quarter and half year ended on 30th September 2021. b) Allotted 19,775 Equity Shares of Rs. 5 each, pursuant to exercise of an option under Employee Stock Option Scheme, 2016. c) Other Routine Businesses. Kindly take a note of the same for your further needful and oblige us. Thanking You,
01-11-2021
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 1St November, 2021.

POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2021 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday, the 1st November, 2021, inter alia to consider the following: a) To consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the Second quarter and half year ended on 30th September, 2021. b) To transact any other matter which the Board may deem fit. This is for your information and record.
19-10-2021
Bigul

POLY MEDICURE LTD. - 531768 - Shareholding for the Period Ended September 30, 2021

Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
18-10-2021
Next Page
Close

Let's Open Free Demat Account